National Pension Service Purchases 22,372 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• National Pension Service increased its Intuitive Surgical stake by 3.1% in the second quarter, purchasing 22,372 shares and ending the period with 749,814 shares valued at approximately $298.2 million. Institutional investors collectively own 83.64% of the company.
• Analysts remain broadly positive, with 22 Buy ratings, eight Holds and one Sell, producing a “Moderate Buy” consensus and an average price target of $508.68, despite several recent target-price reductions.
• Intuitive Surgical reported stronger-than-expected quarterly results, including $2.80 in adjusted EPS and $2.89 billion in revenue, with revenue rising 18.4% year over year. Shares opened at $353.24, well below their 52-week high of $603.88, amid concerns about slower procedure growth, costs and competition.

National Pension Service grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 749,814 shares of the medical equipment provider's stock after acquiring an additional 22,372 shares during the quarter. National Pension Service owned about 0.21% of Intuitive Surgical worth $298,186,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. California State Teachers Retirement System grew its holdings in Intuitive Surgical by 39,531.1% during the 2nd quarter. California State Teachers Retirement System now owns 213,725,958 shares of the medical equipment provider's stock valued at $84,994,539,000 after purchasing an additional 213,186,670 shares during the last quarter. Norges Bank purchased a new stake in Intuitive Surgical in the 4th quarter worth about $2,856,987,000. Bank of New York Mellon Corp bought a new stake in Intuitive Surgical in the second quarter worth about $1,335,753,000. J. Stern & Co. LLP boosted its position in shares of Intuitive Surgical by 18,504.6% during the fourth quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider's stock valued at $1,204,788,000 after buying an additional 2,115,814 shares during the period. Finally, Northwestern Mutual Wealth Management Co. boosted its position in shares of Intuitive Surgical by 1,043.3% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 1,342,121 shares of the medical equipment provider's stock valued at $760,124,000 after buying an additional 1,224,734 shares during the period. Institutional investors own 83.64% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Truist Financial reduced their price target on Intuitive Surgical from $580.00 to $510.00 and set a "buy" rating on the stock in a report on Thursday, July 16th. Sanford C. Bernstein restated an "outperform" rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Robert W. Baird cut their price objective on Intuitive Surgical from $525.00 to $500.00 and set an "outperform" rating on the stock in a research report on Friday, July 17th. Citigroup reduced their target price on Intuitive Surgical from $590.00 to $500.00 and set a "buy" rating on the stock in a research note on Friday, July 17th. Finally, BTIG Research reiterated a "buy" rating and set a $469.00 target price on shares of Intuitive Surgical in a research report on Tuesday. Twenty-two investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $508.68.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Mark Brosius sold 77 shares of the stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $375.57, for a total transaction of $28,918.89. Following the transaction, the executive vice president directly owned 881 shares in the company, valued at $330,877.17. This represents a 8.04% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy Ladd sold 72 shares of the firm's stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $393.10, for a total transaction of $28,303.20. Following the transaction, the director directly owned 179 shares in the company, valued at $70,364.90. This trade represents a 28.69% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 11,281 shares of company stock valued at $4,485,432 in the last ninety days. 0.60% of the stock is owned by insiders.

Intuitive Surgical Stock Up 0.9%

Shares of NASDAQ:ISRG opened at $353.24 on Thursday. The business's 50 day moving average is $378.72 and its 200 day moving average is $425.22. The stock has a market cap of $124.79 billion, a P/E ratio of 40.46, a price-to-earnings-growth ratio of 2.64 and a beta of 1.47. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The business had revenue of $2.89 billion during the quarter, compared to analysts' expectations of $2.83 billion. During the same period in the prior year, the business earned $1.81 EPS. The business's revenue for the quarter was up 18.4% compared to the same quarter last year. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: A large meta-analysis found that da Vinci robotic-assisted surgery was associated with statistically significant improvements across 13 common benign conditions, including shorter hospital stays and faster returns to work versus laparoscopic and open surgery. The findings support the clinical value of Intuitive’s platform and could help drive hospital adoption. New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery
• Positive Sentiment: BTIG reaffirmed its “buy” rating and assigned a $469 price target, implying substantial upside from recent trading levels. Other analyst commentary also remains broadly favorable, although investors may be discounting some recommendations because sell-side ratings tend to be optimistic. BTIG reaffirms buy rating on Intuitive Surgical
• Positive Sentiment: Articles note that ISRG is trading at its cheapest valuation in roughly a decade. Combined with recent revenue growth of about 18% and strong earnings execution, the lower valuation is attracting interest from value-oriented investors. ISRG stock trading at its cheapest in 10 years
• Neutral Sentiment: Intuitive presented at the Wells Fargo Healthcare Conference, keeping investor attention on procedure trends, guidance, competition, and the company’s long-term robotic-surgery opportunity. Intuitive Surgical Wells Fargo Healthcare Conference transcript
• Negative Sentiment: Recent selling pressure has been linked to slower U.S. procedure growth, rising costs, competitive threats, and potential effects from GLP-1 drugs. Investors are also questioning whether the company’s earnings multiple is justified while growth moderates. Why Intuitive Surgical fell more than the broader market
• Negative Sentiment: EVP Mark Brosius reported two sales totaling 69 shares. The transactions were made under a pre-arranged Rule 10b5-1 plan and are small relative to his remaining holdings, limiting their significance; however, broader insider activity has consisted predominantly of sales rather than purchases.

Intuitive Surgical Profile

Intuitive Surgical, Inc is a medical technology company that develops and manufactures robotic-assisted surgical systems and related products. Its technology is designed to support surgeons during minimally invasive procedures by providing enhanced visualization, instrument control and dexterity.

The company's principal product is the da Vinci Surgical System, which is used across a range of specialties, including general surgery, urology, gynecology, cardiothoracic surgery and other procedures.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.